Skip to content

Clinical trials

Phase 1/2 Cerebral Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebral Hemorrhage Phase: Phase 1/2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20134
20151
20181
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status4
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Augusta University1
Capital Medical University1
CellMed AG, a subsidiary of BTG plc.1
Chinese University of Hong Kong1
Hokkaido University Hospital1
Sheba Medical Center1
Tang Zhouping1
Tang-Du Hospital1
Thomas Jefferson University1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebral Hemorrhage11
Hyperthermia2
Stroke2
Brain Injuries, Traumatic1
Bronchiolitis Obliterans Syndrome1
Fever1
Hematoma, Subdural1
Hemorrhage1
Hemorrhagic Stroke1
Hypothermia1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.